A shortage of a chemotherapy drug used to treat cancer in children highlights the serious perils of the rampant shortage problem facing the industry. "It’s our bread and butter," said Dr. Yoram Unguru, a pediatric oncologist. "There is no substitution ... You either have to skip a dose or give a lower dose — or beg, borrow or plead." While the FDA has been trying to address the issue of shortages it's fallen short in its efforts to grant addition approval of generics. Meanwhile, companies are trying other methods to combat the problem.

from Kaiser Health News https://ift.tt/2qi6Gk5

Related Posts:

0 comments:

Post a Comment

Popular Posts